Neurogenic Bladder Disorder: Clinical Trials

1 terminated. 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	1	Terminated 1

Follow Neurogenic Bladder Disorder: new trials by email Literature Review of Neurogenic Bladder Disorder trials Research Report on Neurogenic Bladder Disorder

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions SAF312, Placebo to SAF312 - Neurogenic Urinary Bladder, Neurogenic Bladder Disorder	Phase 2	Terminated	Novartis Pharmaceuticals	9	2012-01-01	2020-12-19

Narrower conditions

Spinal Cord Injuries (1)  ·  Urinary Bladder, Neurogenic (1)

Broader conditions

Central Nervous System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Male Urogenital Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Spinal Cord Diseases (1)  ·  Trauma, Nervous System (1)  ·  Urinary Bladder Diseases (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)  ·  Wounds and Injuries (1)

Sponsors

Novartis Pharmaceuticals (1)

Countries

Germany (1)  ·  Netherlands (1)  ·  Switzerland (1)